News

Hosted by Horizon 3 Biotech Chief Investment Officer Matt McNamaraIn this episode Matt will be joined by John Melki CEO of Genetic Signatures, Dr Paul Gavin of Avecho and Michael Woods. https://youtu.be/ZFHrz2ixboY

Hosted by Horizon 3 Biotech Chief Investment Officer Matt McNamara In this episode Matt will be joined by Dr Chris Baldwin, Deputy CEO and Chief Commercial Officer of Exopharm, and Dirk van Dissel Founder of Candour Advisory. https://youtu.be/7mHgJOGZ2Eg

Hosted by Horizon 3 Biotech Chief Investment Officer Matt McNamaraIn this episode Matt will be joined by Simon Davidson from Lander & Rogers and Deborah Rathjen from Carina Biotech. https://youtu.be/8Gz9i3bfnR8

Hosted by Horizon 3 Biotech Chief Investment Officer Matt McNamaraIn this episode Matt will be joined by Rosemary Cummins of MST Financial and Ralph Highnam of Volpara Health Technologies. https://youtu.be/JhsUH91rYGA

Hosted by Horizon 3 Biotech Chief Investment Officer Matt McNamara In this episode Matt will be joined by Tony Locantro from Alto Capital and Sue MacLennan a Senior Biotechnology and Medical Technology Executive. https://youtu.be/NfSb_6KYM_k

Hosted by Horizon 3 Biotech Chief Investment Officer Matt McNamara In this episode Matt will be joined by Investment Analyst Scott Power at Morgans to discuss healthcare investment and the outlook for 2021. Malcolm McColl, CEO & Co-Founder of ImmVirX…

Hosted by Horizon 3 Biotech Chief Investment Officer Matt McNamara Matt MacNamara, Chief Investment Officer at Horizon 3 Biotech &  Scott Power, Investment Committee at Horizon 3 Biotech speaks to Dr Nina Webster, Dimerix Ltd CEO & MD Dr Matthijs…

Hosted by Horizon 3 Biotech Chief Investment Officer Matt McNamara Matt MacNamara, Chief Investment Officer at Horizon 3 Biotech &  Scott Power, Investment Committee at Horizon 3 Biotech   https://youtu.be/_rlNEiMBzYw

Hosted by Horizon 3 Biotech Chief Investment Officer Matt McNamara In this episode Matt will be joined by Chris Behrenbruch from Telix Pharmaceuticals and David Blake. https://youtu.be/kLdf055FDD8

Hosted by Horizon 3 Biotech Chief Investment Officer Matt McNamara In this episode Matt will be joined by Opthea CEO & Managing Director Dr Megan Baldwin and Phamaxis CEO Gary Phillips. https://youtu.be/L6GqZCneUqw

Hosted by Horizon 3 Biotech Chief Investment Officer Matt McNamara In this episode Matt will be joined by Horizon 3 Biotech Life Sciences and Capital Markets Executive Dr Graeme Wald and Investment Analyst Scott Power who will be sharing topical…

This Guide to Life Sciences Investing, with foreword from Horizon 3's Board member Glenn Cross, will provide potential investors in life sciences companies with consolidated, factual, relevant and independent information about the sector. It builds on general investment guidance by featuring…